The Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS).
• Dysregulation of GABAergic signaling is implicated in neurodevelopmental disorders (NDDs) such as schizophrenia (SZ), autism spectrum disorder (ASD), major depressive disorder (MDD), bipolar disorder (BD), and intellectual disability (ID).

Purpose of the Study:

• To review and analyze the literature on the GABA pathway's components and their involvement in NDD pathogenesis.
• To explore potential undiscovered mechanisms that maintain GABA levels when glutamic acid decarboxylase function is compromised.
• To identify potential therapeutic targets for NDDs by understanding GABA metabolism.

Main Methods:

• Literature review and data analysis of the GABA pathway.
• Description of GABA synthesis, release, receptor neurotransmission, reuptake, and catabolism.
• Evaluation of the GABA pathway's role in the pathogenesis of NDDs.

Main Results:

• GABAergic signaling disruptions are key contributors to various NDDs.
• The GABA pathway's metabolic stage may have a minor direct effect on signaling but can cause clinical effects through neurotoxic byproduct accumulation.
• Undescribed mechanisms may maintain physiological GABA levels despite compromised glutamic acid decarboxylase function.

Conclusions:

• Understanding GABA metabolism and its disruptions is crucial for NDD research.
• Identifying novel mechanisms in GABA homeostasis could lead to new therapeutic strategies for BD and SZ.
• Focusing on neurotoxic byproduct accumulation offers insights into NDD clinical manifestations.